小分子
选项
-
SB742457CAS号 : 607742-69-8(DMSO)分子式: C19H19N3O2S 分子量: 353.44SMILES: O=[S](=O)(C1=CC=CC=C1)C2=CC3=C(N=C2)C(=CC=C3)N4CCNCC4
-
利哌酮CAS号 : 106266-06-2(DMSO)分子式: C23H27FN4O2 分子量: 410.48SMILES: CC1=C(CCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)C(=O)N5CCCCC5=N1
-
多潘立酮CAS号 : 57808-66-9(DMSO)分子式: C22H24ClN5O2 分子量: 425.91SMILES: ClC1=CC2=C(C=C1)N(C3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2
-
氟哌啶醇CAS号 : 52-86-8(DMSO)分子式: C21H23ClFNO2 分子量: 375.86SMILES: OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
-
氯氮平CAS号 : 5786-21-0(DMSO)分子式: C18H19ClN4 分子量: 326.82SMILES: CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(=C3)Cl
-
米尔塔扎平CAS号 : 85650-52-8(DMSO)分子式: C17H19N3 分子量: 265.35SMILES: CN1CCN2C(C1)C3=C(CC4=C2N=CC=C4)C=CC=C3
-
脱羧氯雷他定CAS号 : 100643-71-8(DMSO)分子式: C19H19ClN2 分子量: 310.82SMILES: ClC1=CC2=C(C=C1)C(=C3CCNCC3)C4=C(CC2)C=CC=N4
-
Ipilimumab (anti-CTLA-4)关联靶标: CTLA4
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<0.01EU/μg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 小鼠(Mouse), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 477202-00-9 Compound CID : 167312542IUPAC Name: 3-butyl-4-hydroxy-5-methyl-5-(2-methylbuta-1,3-dienyl)thiophen-2-one;4-ethyl-2-methyl-2-(2-methylbuta-1,3-dienyl)-5-methylidenethiophen-3-ol;4-hydroxy-5-methyl-5-(2-methylbuta-1,3-dienyl)-3-[4-(4-methylphenyl)butyl]thiophen-2-one;4-hydroxy-5-methyl-5-(2-methylbuta-1,3-dienyl)-3-[2-(4-methylphenyl)ethyl]thiophen-2-one;4-hydroxy-5-methyl-5-(2-methylbuta-1,3-dienyl)-3-propylthiophen-2-oneSMILES: CCCCC1=C(C(SC1=O)(C)C=C(C)C=C)O.CCCC1=C(C(SC1=O)(C)C=C(C)C=C)O.CCC1=C(C(SC1=C)(C)C=C(C)C=C)O.CC1=CC=C(C=C1)CCCCC2=C(C(SC2=O)(C)C=C(C)C=C)O.CC1=CC=C(C=C1)CCCCC2=C(C(SC2=O)(C)C=C(C)C=C)O.CC1=CC=C(C=C1)CCCCC2=C(C(SC2=O)(C)C=C(C)C=C)O.CC1=CC=C(C=C1)CCCCC2=C(C(SC2=O)(C)C=C(C)C=C)O.CC1=CC=C(C=C1)CCC2=C(C(SC2=O)(C)C=C(C)C=C)O.CC1=CC=C(C=C1)CCC2=C(C(SC2=O)(C)C=C(C)C=C)OInChIKey: QZWDCJBBGBXHMW-UHFFFAOYSA-NInChI: InChI=1S/4C21H26O2S.2C19H22O2S.C14H20O2S.C13H18O2S.C13H18OS/c4*1-5-15(2)14-21(4)19(22)18(20(23)24-21)9-7-6-8-17-12-10-16(3)11-13-17;2*1-5-13(2)12-19(4)17(20)16(18(21)22-19)11-10-15-8-6-14(3)7-9-15;1-5-7-8-11-12(15)14(4,17-13(11)16)9-10(3)6-2;1-5-7-10-11(14)13(4,16-12(10)15)8-9(3)6-2;1-6-9(3)8-13(5)12(14)11(7-2)10(4)15-13/h4*5,10-14,22H,1,6-9H2,2-4H3;2*5-9,12,20H,1,10-11H2,2-4H3;6,9,15H,2,5,7-8H2,1,3-4H3;6,8,14H,2,5,7H2,1,3-4H3;6,8,14H,1,4,7H2,2-3,5H3 -
阿莫沙平CAS号 : 14028-44-5分子式: C17H16ClN3O 分子量: 313.78IUPAC Name: 8-chloro-6-piperazin-1-ylbenzo[b][1,4]benzoxazepineSMILES: C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)ClInChIKey: QWGDMFLQWFTERH-UHFFFAOYSA-NInChI: InChI=1S/C17H16ClN3O/c18-12-5-6-15-13(11-12)17(21-9-7-19-8-10-21)20-14-3-1-2-4-16(14)22-15/h1-6,11,19H,7-10H2
-
AzaperoneCAS号 : 1649-18-9分子式: C19H22FN3O 分子量: 327.4IUPAC Name: 1-(4-fluorophenyl)-4-(4-pyridin-2-ylpiperazin-1-yl)butan-1-oneSMILES: C1CN(CCN1CCCC(=O)C2=CC=C(C=C2)F)C3=CC=CC=N3InChIKey: XTKDAFGWCDAMPY-UHFFFAOYSA-NInChI: InChI=1S/C19H22FN3O/c20-17-8-6-16(7-9-17)18(24)4-3-11-22-12-14-23(15-13-22)19-5-1-2-10-21-19/h1-2,5-10H,3-4,11-15H2
-
阿司咪唑CAS号 : 68844-77-9分子式: C28H31FN4O 分子量: 458.57IUPAC Name: 1-[(4-fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl]benzimidazol-2-amineSMILES: COC1=CC=C(C=C1)CCN2CCC(CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(C=C5)FInChIKey: GXDALQBWZGODGZ-UHFFFAOYSA-NInChI: InChI=1S/C28H31FN4O/c1-34-25-12-8-21(9-13-25)14-17-32-18-15-24(16-19-32)30-28-31-26-4-2-3-5-27(26)33(28)20-22-6-10-23(29)11-7-22/h2-13,24H,14-20H2,1H3,(H,30,31)
-
苄索氯铵CAS号 : 121-54-0分子式: C27H42ClNO2 分子量: 448.08IUPAC Name: benzyl-dimethyl-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]azanium;chlorideSMILES: CC(C)(C)CC(C)(C)C1=CC=C(C=C1)OCCOCC[N+](C)(C)CC2=CC=CC=C2.[Cl-]InChIKey: UREZNYTWGJKWBI-UHFFFAOYSA-MInChI: InChI=1S/C27H42NO2.ClH/c1-26(2,3)22-27(4,5)24-13-15-25(16-14-24)30-20-19-29-18-17-28(6,7)21-23-11-9-8-10-12-23;/h8-16H,17-22H2,1-7H3;1H/q+1;/p-1